Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Catamenial Pneumothorax
GnRH agonists and pleural symphysis augmentation recommended for treatment
June 9th, 2005
Thoracic surgeons at Georgetown University Hospital recommend the use of gonadotropin releasing hormone (GnRH) agonists before or after surgery in women at high risk for catamenial pneumothorax, as well as intervention to augment pleural symphysis at the level of the diaphragm. Catamenial pneumothorax refers to the presence of free air or gas in the pleural cavity occurring during menstruation, primarily in younger women. The Georgetown University Hospital team, in Washington, DC, analyzed data from medical records of female patients operated on for spontaneous pneumothorax between January 1993 and March 2002 "to provide further information...
Source: Women's Health Weekly (2005-06-09)
|
